Zobrazeno 1 - 10
of 543
pro vyhledávání: '"A S, Belldegrun"'
Autor:
Beata Berent-Maoz, Ankush Sachdeva, Thinle Chodon, Paula Cabrera, Jonathan W. Said, Allan J. Pantuck, Gardenia Cheung-Lau, Alexandra Drakaki, Izak Faiena, Begoña Comin-Anduix, Paula Kaplan-Lefko, Arie S. Belldegrun, Xiaoyan Wang, Nazy Zomorodian, Karim Chamie, Jia Pang, Adrian Bot, Mignonette H. Macabali
Publikováno v:
Journal of Immunotherapy. 43:273-282
Expression of carbonic-anhydrase IX (CAIX) in clear cell renal cell carcinoma (RCC) makes it an attractive vaccine target. We developed a fusion-gene construct, granulocyte-macrophage (GM) colony-stimulating factor+CAIX, delivered by an adenoviral ve
Autor:
Allan J. Pantuck, Frank Dombrowski, Shahrokh F. Shariat, Martin Burchardt, Arie S. Belldegrun, Tobias Klatte, Nils Kroeger, Silvia Ribback, Alexandra Drakaki, Johannes Heide
Publikováno v:
World Journal of Urology. 38:1525-1533
Co-morbidities may induce local and systemic tumor progression of renal cell carcinoma (RCC); however, the prognostic impact of co-morbidities has not yet been well characterized. RCC patients (n = 2206) surgically treated at three academic instituti
Autor:
Anthony Sisk, Allan J. Pantuck, Arie S. Belldegrun, Steven S. Raman, Jonathan R. Young, Hyun J. Kim, Heidi Coy, Michael Douek
Publikováno v:
Abdominal Radiology. 43:2734-2742
To investigate if multiphasic multidetector computed tomography (MDCT) enhancement profiles can distinguish clear cell renal cell carcinomas (ccRCCs) with high carbonic anhydrase-IX (CA-IX) expression from ccRCCs with low CA-IX expression. With IRB a
Autor:
Richard J. Kahnoski, Arie S. Belldegrun, Weng Khong Lim, Hyung L. Kim, Hiro-omi Kanayama, Xiaona Wei, Min-Han Tan, Bin Tean Teh, Brian R. Lane, John Anema, John Ludlow, Craig G. Rogers, Yukti Choudhury, Masayuki Takahashi, David Nicol
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports
Scientific Reports
PURPOSEEvaluation of 12 ccRCC publicly-available ccRCC gene expression datasets showed that previously proposed discrete molecular subtypes are unstable. To reflect the continuous nature of gene expression observed, we developed a quantitative score
Autor:
Nils Kroeger, Allan J. Pantuck, Cedric Lebacle, Aydin Pooli, Erika L. Wood, Karim Chamie, Alexandra Drakaki, Grace-Hyun Kim, Izak Faiena, Nagesh Rao, Brian Shuch, Sandy T. Liu, Arie S. Belldegrun
Publikováno v:
Journal of Urology. 201
Autor:
Arie S. Belldegrun, Karim Chamie, Jonathan W. Said, Barbara Fall, Nicholas M. Donin, Allan J. Pantuck, Pia Klöpfer, Paul Bevan
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:1326-1332
Background: The relationship between adiposity and renal cell carcinoma is poorly understood. Prior studies have suggested body mass index (BMI) may be associated with indolent disease. Methods: We reviewed the clinicopathologic records of 845 patien
Autor:
Johannes, Heide, Silvia, Ribback, Tobias, Klatte, Shahrokh, Shariat, Martin, Burchardt, Frank, Dombrowski, Arie S, Belldegrun, Alexandra, Drakaki, Allan J, Pantuck, Nils, Kroeger
Publikováno v:
World journal of urology. 38(6)
Co-morbidities may induce local and systemic tumor progression of renal cell carcinoma (RCC); however, the prognostic impact of co-morbidities has not yet been well characterized.RCC patients (n = 2206) surgically treated at three academic institutio
Autor:
Karim Chamie, Rajul K. Jain, Allan J. Pantuck, Alexandra Drakaki, Stephanie H. Astrow, Arie S. Belldegrun, Izak Faiena, David Elashoff, Adrian Bot
Publikováno v:
Cancer immunology, immunotherapy : CII. 68(5)
Melanoma-associated antigen-A (MAGE-A) and programmed-death ligand 1 (PD-L1) are present in urothelial carcinoma (UC). We assessed survival outcomes in patients with MAGE-A and PD-L1 expression. MAGE-A and PD-L1 expression on neoplastic cells was ana
Autor:
Nils Kroeger, Sebastian Fussek, J. Huang, Sandra Leisz, Arie S. Belldegrun, Barbara Seliger, D. Brandstetter, B. Dougall, Allan J. Pantuck, Behdokht Nowroozizadeh, Martin Burchardt, André Steven
Publikováno v:
Urologic oncology. 36(11)
Inhibition of the receptor activator of NF-κB ligand (RANKL) has become a standard of care supportive treatment to prevent skeletal related events in cancer patients. Moreover, RANKL inhibition has been implicated with better survival outcome in lun
Autor:
Nils Kroeger, Cedric Lebacle, Izak Faiena, Brian Shuch, Aydin Pooli, Alexandra Drakaki, Karim Chamie, E.L. Wood, Arie S. Belldegrun, N. Rao, S.T. Liu, G. Kim, A. Pantuck
Publikováno v:
European Urology Supplements. 18:e92-e93